ZBH
What one share of Zimmer Biomet Holdings holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (“CMFT”) products; bone cement; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
Zimmer Biomet Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $43.33 |
|---|---|
| Profit | $4.11 |
| Capex (buildings and equipment) | $1.12 |
| Free cash flow | $7.76 |
| Dividends | $0.96 |
| Cash and investments | $2.15 |
| Debt | $39.21 |
| Book value | $66.18 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $37.89 | $1.51 | $0.91 | $7.15 | $0.96 | $48.08 |
| 2017 | $38.31 | $8.90 | $0.77 | $7.00 | $0.96 | $57.77 |
| 2018 | $38.98 | −$1.86 | $0.80 | $7.79 | $0.96 | $55.13 |
| 2019 | $38.62 | $5.47 | $1.00 | $6.67 | $0.96 | $60.02 |
| 2020 | $29.60 | −$0.67 | $0.54 | $5.28 | $0.96 | $58.67 |
| 2021 | $32.45 | $1.91 | $0.68 | $6.44 | $0.96 | $60.53 |
| 2022 | $33.00 | $1.10 | $0.89 | $5.56 | $0.96 | $57.52 |
| 2023 | $35.26 | $4.88 | $1.39 | $6.15 | $0.96 | $60.86 |
| 2024 | $37.66 | $4.43 | $1.00 | $6.35 | $0.96 | $62.63 |
| 2025 | $41.43 | $3.55 | $1.13 | $7.41 | $0.96 | $64.90 |